TECX Stock Price | Tectonic Therapeutic, Inc. P/E, Revenue, EPS, & Forecasts

Tectonic Therapeutic, Inc. • TECX

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Tectonic Therapeutic, Inc.

Ticker

TECX

Trading on

NASDAQ

ISIN

US8789721086

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Alise S. Reicin M.D., Ph.D.

Headquarters

490 Arsenal Way, Watertown, MA, United States, 02472

Employees

Website

https://tectonictx.com

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Metrics

BasicAdvanced

Market cap

$378M

P/E ratio

EPS

-$2.69

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-75M

Ex dividend date

Price & volume

Market cap

$378M

Average daily volume

0.4M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

1.41

Earnings

EPS

-$2.69

EPS estimate (current quarter)

-$1.07

EPS estimate (next quarter)

-$1.09

EBITDA

$-75M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

52-week High

$61.07

52-week Low

$13.70

50-day moving average

$17.60

200-day moving average

$20.41

Short ratio

7.77

Short %

47.05%

Management effectiveness

ROE (TTM)

-32.21%

ROA (TTM)

-21.46%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

18.7M

Float

11.1M

Insiders %

38.38%

Institutions %

64.96%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 6 analysts.

Average price target

$78.71

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.84

-$1.39

39.68%

Q4 • 24Beat

-$0.93

-$1.09

14.87%

Q1 • 25Beat

-$1.07

-$1.32

18.94%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-20M

-∞%

Q2 • 25

$0M

$-19M

-∞%

Q3 • 25

NaN%

-4.75%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$295M

$11.5M

3.91%

Q2 • 25

$277M

$9.5M

3.42%

Q3 • 25

-6.20%

-17.96%

-12.54%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-14.7M

$0.1M

$-4.2M

$-14.7M

Q2 • 25

$-17.8M

$-0.2M

$-0.5M

$-18M

Q3 • 25

21.03%

-401.82%

-89.04%

22.04%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Tectonic Therapeutic, Inc. share?

Tectonic Therapeutic, Inc. shares are currently traded for undefined per share.

How many shares does Tectonic Therapeutic, Inc. have?

Tectonic Therapeutic, Inc. currently has 18.7M shares.

Does Tectonic Therapeutic, Inc. pay dividends?

No, Tectonic Therapeutic, Inc. doesn't pay dividends.

What is Tectonic Therapeutic, Inc. 52 week high?

Tectonic Therapeutic, Inc. 52 week high is $61.07.

What is Tectonic Therapeutic, Inc. 52 week low?

Tectonic Therapeutic, Inc. 52 week low is $13.70.

What is the 200-day moving average of Tectonic Therapeutic, Inc.?

Tectonic Therapeutic, Inc. 200-day moving average is $20.41.

Who is Tectonic Therapeutic, Inc. CEO?

The CEO of Tectonic Therapeutic, Inc. is Dr. Alise S. Reicin M.D., Ph.D..

How many employees Tectonic Therapeutic, Inc. has?

Tectonic Therapeutic, Inc. has 51 employees.

What is the market cap of Tectonic Therapeutic, Inc.?

The market cap of Tectonic Therapeutic, Inc. is $378M.

What is the P/E of Tectonic Therapeutic, Inc.?

The current P/E of Tectonic Therapeutic, Inc. is null.

What is the EPS of Tectonic Therapeutic, Inc.?

The EPS of Tectonic Therapeutic, Inc. is -$2.69.

What is the PEG Ratio of Tectonic Therapeutic, Inc.?

The PEG Ratio of Tectonic Therapeutic, Inc. is null.

What do analysts say about Tectonic Therapeutic, Inc.?

According to the analysts Tectonic Therapeutic, Inc. is considered a buy.